Impact of Duodenal-Jejunal Exclusion on Satiety Hormones
- C. de Jonge; S. S. Rensen; F. J. Verdam; R. P. Vincent; S. R. Bloom; W. A. Buurman; C. W. le Roux; N. D. Bouvy; J. W. Greve Impact of Duodenal-Jejunal Exclusion on Satiety Hormones Obes Surg
Insulin Resistance & Diabetes
Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment
- G. Del Genio; M. Gagner; P. Limongelli; S. Tolone; D. Pournaras; C. W. le Roux; L. Brusciano; A. Licia Mozzillo; F. Del Genio; L. Docimo Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment Surg Obes Relat Dis
Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis
- R. Cohen; C. W. Le Roux; S. Junqueira; R. A. Ribeiro; A. Luque Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis Obes Surg
Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes
- R. Cohen; C. W. le Roux; D. Papamargaritis; J. E. Salles; T. Petry; J. L. Correa; D. J. Pournaras; M. Galvao Neto; B. Martins; P. Sakai; C. A. Schiavon; C. Sorli Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes Diabetic Medicine
Another look at the (endoscopic duodenal liner) ENDO trial, or how to avoid the burial of a valuable antidiabetic tool
- R. Cohen; M. P. Galvão Neto; C. L. Roux Another look at the (endoscopic duodenal liner) ENDO trial, or how to avoid the burial of a valuable antidiabetic tool Surg Obes Relat Dis
The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes-Reply
- R. V. Cohen; T. V. Pereira; C. W. le Roux The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes-Reply JAMA Surg
Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial
- R. V. Cohen; T. V. Pereira; C. M. Aboud; P. P. Caravatto; T. B. Petry; J. L. Correa; C. A. Schiavon; M. Correa; C. E. Pompílio; F. N. Pechy; C. W. le Roux Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial BMJ Open
Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial
- R. V. Cohen; T. V. Pereira; C. M. Aboud; T. B. Z. Petry; J. L. Lopes Correa; C. A. Schiavon; C. E. Pompílio; F. N. Q. Pechy; A. C. C. da Costa Silva; F. L. G. de Melo; L. P. Cunha da Silveira; P. P. de Paris Caravatto; H. Halpern; F. L. J. Monteiro; B. da Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial JAMA Surg
Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery
- L. L. Chuah; A. D. Miras; D. Papamargaritis; S. N. Jackson; T. Olbers; C. W. le Roux Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery Surg Obes Relat Dis
Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device
- J. Casella-Mariolo; L. Castagneto-Gissey; G. Angelini; A. Zoli; P. Marini; S. R. Bornstein; D. J. Pournaras; F. Rubino; C. W. le Roux; G. Mingrone; G. Casella Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device EBioMedicine